Medriva's COVID-19 Rapid Antigen Self-Test Kit is tailored for at-home use, enabling users to detect the SARS-CoV-2 nucleocapsid antigen quickly. This self-test is user-friendly and yields results in approximately 15-20 minutes, making it an efficient tool for monitoring health during the pandemic. With a sensitivity rate of 95% and a specificity rate of 99%, it ensures accurate results for effective decision-making regarding one’s health.

BaseRock.ai is an innovative QA platform that leverages artificial intelligence to automate unit and integration testing processes. Designed to be user-friendly, it requires zero learning curve, making it easy for developers and QA teams to produce and run test cases with a single click. This platform ensures maximum test coverage, detects bugs early, and provides detailed feedback to boost developer productivity. Additionally, BaseRock.ai integrates seamlessly into CI/CD pipelines, which enables frequent and reliable software deployments.